Cantor Fitzgerald Reiterates Overweight Rating on Xencor, Inc. (XNCR)

Market Context

Xencor, Inc. operates in the Healthcare sector. The stock currently trades at $19.49 with a market capitalization of $1.2B. The stock has gained 149.6% over the past 52 weeks.

Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Xencor, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Xencor, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 06, 2026	Cantor Fitzgerald	Overweight	N/A
Jul 30, 2026	Wedbush	Outperform	N/A
Jul 07, 2026	Truist Securities	Buy	N/A
May 11, 2026	JP Morgan	Neutral	N/A
Mar 24, 2026	JP Morgan	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View XNCR Stock Page